CL
APTO

CSS LLC’s Aptose Biosciences, Inc. APTO Stock Holding History

CSS LLC’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3
Closed -$5K – 1358
2021
Q2 		$5K Sell
3
-16
-84% -$34.9K ﹤0.01% 1054
2021
Q1 		$51K Buy
+19
New +$37.7K ﹤0.01% 864
2020
Q4 		– Sell
-94
Closed -$254K – 976
2020
Q3 		$254K Buy
94
+25
+36% +$62.3K 0.01% 536
2020
Q2 		$197K Buy
69
+21
+44% +$67.7K 0.01% 490
2020
Q1 		$128K Buy
+48
New +$143K 0.01% 475

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

CSS LLC's APTO Position: Q3 2021 in Review

CSS LLC sold out of Aptose Biosciences, Inc. (APTO) in Q3 2021, closing a stake of 3 shares — an estimated $5K sold.

CSS LLC first reported a position in APTO in Q1 2020 and held it in 5 quarters. The position peaked at $254K in Q3 2020. 64 funds tracked by Wall St. Rank hold APTO as of Q3 2021.

  • CSS LLC reported no remaining Aptose Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • CSS LLC sold 3 Aptose Biosciences, Inc. shares in Q3 2021, an estimated $5K.
  • CSS LLC first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 5 quarters.
  • CSS LLC's Aptose Biosciences, Inc. position peaked at $254K in Q3 2020.
  • 64 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2021.

Based on CSS LLC's 13F filing for Q3 2021, filed 15 Nov 2021.